电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant EGFR (Panitumumab Biosimilar) 抗体

This anti-EGFR (Panitumumab Biosimilar) antibody is a 小鼠 单克隆 antibody detecting EGFR (Panitumumab Biosimilar) in FACS 和 in vivo. Suitable for 人.
产品编号 ABIN7200662
发货至: 中国

Quick Overview for Recombinant EGFR (Panitumumab Biosimilar) 抗体 (ABIN7200662)

抗原

EGFR (Panitumumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 1
  • 1
小鼠

克隆类型

  • 2
单克隆

标记

  • 2
This EGFR (Panitumumab Biosimilar) antibody is un-conjugated

应用范围

Flow Cytometry (FACS), In vivo Studies (in vivo)
  • 原理

    Panitumumab Biosimilar, Human EGFR/ErbB-1/HER1 Monoclonal Antibody

    特异性

    The monoclonal antibody panitumumab biosimilar specifically binds to the human EGFR, ErbB-1 and HER1.

    产品特性

    Recombinant Humanized IgG2 Monoclonal Antibody.

    纯化方法

    Protein A affinity column

    纯度

    > 95% by SDS-PAGE under reducing conditions and HPLC.

    过滤

    0.2 μm filtered

    内毒素水平

    < 1 EU per 1 mg of the protein by the LAL method.

    免疫原

    The monoclonal antibody panitumumab biosimilar was produced in the Panitumumab biosimilar CHO stable cell line.

    亚型

    IgG2 kappa
  • 应用备注

    ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by panitumumab.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    1 mg/mL

    缓冲液

    PBS, pH 7.4, no stabilizers or preservatives.

    储存液

    Without preservative

    注意事项

    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

    储存条件

    -20 °C

    储存方法

    12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.

    有效期

    12 months
  • 抗原

    EGFR (Panitumumab Biosimilar)

    物质类

    Biosimilar

    背景

    Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".
You are here:
Chat with us!